ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugNeopharmed Gentili Schweiz GmbH
Neopharmed Gentili Schweiz GmbH Logo
Verified· 2 sources

Neopharmed Gentili Schweiz GmbH

Summary

About the company

The core activity of BioCryst is the development and commercialization of medicines for rare diseases, particularly hereditary angioedema (HAE) and other rare disorders. The company focuses on the development of oral small molecules and protein therapeutics based on a combination of traditional biology, medicinal chemistry, and advanced technologies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered5
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Rare Disease Medicines
Oral small-molecule and injectable protein therapeutics for hereditary angioedema and other rare diseases, including approved and pipeline medicines.
Research and Development
Research, drug discovery and clinical development for oral small molecules and injectable protein therapeutics in HAE, Netherton syndrome and other rare diseases.
Patient Support
Patient-centred support with patient input, advocacy activities, grants and donations for rare-disease communities.
Medical Information
Medical information for healthcare professionals about approved or pipeline medicines, with access to medical science liaisons.
Expanded Access to Investigational Medicines
Case-by-case review of physician requests for out-of-trial access to investigational medicines for serious or life-threatening diseases.

Knowledge

No knowledge articles yet

Once Neopharmed Gentili Schweiz GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Neopharmed Gentili Schweiz GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neopharmed Gentili Schweiz GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neopharmed Gentili Schweiz GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 10
6300 Zug
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Limited Liability Company
UID
CHE-455.845.799
Founded
2021 · 5 years
Last commercial register change
September 25, 2026
Employees
11 to 20

Similar companies

C(
Cytokinetics (Switzerland) GmbH
Zug
AS
Alnylam Switzerland GmbH
Zug
BM
Blueprint Medicines (Switzerland) GmbH
Zug
QP
Quercis Pharma AG
Zug
JP
Jazz Pharmaceuticals Switzerland GmbH
Zug
VP
Vertex Pharmaceuticals (CH) GmbH
Zug
BI
BridgeBio International GmbH
Zug
ST
SpringWorks Therapeutics Europe GmbH
Zug